Fioricet Articles
USA's Consumer Reports warns pain pills can worsen headaches
8 September 2008
Novartis completes $178 mill headache drug sale
17 February 2003
Watson pays $178M for Novartis headache drugs
27 January 2003
Showing 1-3 of 3 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
